Form PRER14C - Information statements:
SEC Accession No. 0001213900-24-072338
Filing Date
2024-08-26
Accepted
2024-08-23 21:52:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 REVISED PRELIMINARY PROXY STATEMENT ea0212329-prer14c_elevai.htm PRER14C 95455
2 GRAPHIC image_001.jpg GRAPHIC 2719
  Complete submission text file 0001213900-24-072338.txt   100487
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14C | Act: 34 | File No.: 001-41875 | Film No.: 241237673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)